PSYREFLECT

Issue #25

March 30, 2026

#1Research

When Pills Fail: Psychotherapy for Treatment-Resistant Depression Finally Gets Its Meta-Analysis

Treatment-resistant depression is not therapy-resistant. The effect is modest, but for patients who have failed two medications, modest is meaningful.

treatment-resistant depressionpsychotherapymeta-analysisCBT
2 minRead analysis
#2Research

DBT or Schema Therapy for BPD? The Answer Depends on the Patient

"Which is better for BPD?" is the wrong question. "Which is better for this patient with BPD?" is the right one — and now we have data to help answer it.

BPDpersonality disordersDBTschema therapy
2 minRead analysis
#3Tool

Attachment Style Predicts Who Recovers From Psychosis — and Who Seeks Help in the First Place

Attachment style does not determine what therapy a psychosis patient needs. It determines whether they will stay long enough to receive it.

attachment theorypsychosisemotion regulationhelp-seeking
2 minRead analysis
#4Industry

The $477 Billion Invoice: What Untreated Mental Illness Costs the US Economy

Depression does not just cost quality of life. It costs $477.5 billion a year in one country. That is not a health statistic — it is an economic emergency.

health economicsdepressionproductivitycost-effectiveness
2 minRead analysis
#5Industry

iCBT Pays for Itself: Productivity Gains and Cost Savings in the Irish Health Service

When a national health service deploys iCBT and measures what happens to workforce productivity, the answer is: it pays for itself.

iCBTdigital mental healthhealth economicsworkplace productivity
2 minRead analysis
#6Resource

DBT-Linehan Board Certification: The Only Credential Endorsed by the Treatment Developer

Many clinicians say they "do DBT." One certification proves they actually do. The treatment developer endorses only this one.

DBTpersonality disorderscertificationprofessional training
3 minRead analysis